The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 15, 2021
Filed:
Sep. 14, 2020
Applicant:
Nimbus Saturn, Inc., Cambridge, MA (US);
Inventors:
Neelu Kaila, Lexington, MA (US);
Ian Linney, Saffron Walden, GB;
Stuart Ward, Saffron Walden, GB;
Grant Wishart, Saffron Walden, GB;
Ben Whittaker, Saffron Walden, GB;
Alexandre Cote, West New York, NJ (US);
Jeremy Robert Greenwood, Brooklyn, NY (US);
Abba Leffler, Bronx, NY (US);
Steven K. Albanese, Brooklyn, NY (US);
Daniel L. Severance, San Diego, CA (US);
Assignee:
Nimbus Saturn, Inc., Cambridge, MA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4035 (2006.01); A61K 31/407 (2006.01); C07D 209/46 (2006.01); C07D 487/04 (2006.01); C07D 471/04 (2006.01); C07D 519/00 (2006.01); C07D 401/14 (2006.01); C07D 495/04 (2006.01); C07D 498/04 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); C07D 401/14 (2013.01); C07D 487/04 (2013.01); C07D 495/04 (2013.01); C07D 498/04 (2013.01); C07D 519/00 (2013.01); C07B 2200/07 (2013.01);
Abstract
The present invention provides compounds of formula I: or pharmaceutically acceptable salts and/or pharmaceutical compositions thereof. The present invention also provides methods for the inhibition of HPK1 and methods for the treatment of HPK1-mediated disorders.